Baadenhuijsen H, Deimann L G, Jansen A P
Department of Internal Medicine, St. Radboud University Hospital, Nijmegen, The Netherlands.
Clin Chim Acta. 1988 Aug 15;176(1):9-16. doi: 10.1016/0009-8981(88)90169-6.
Lack of satisfactory literature evidence and experiences with results of quality control assessment trials in The Netherlands prompted reconsideration of the determination of total iron-binding capacity (TIBC) in human and control sera. It was found that for a correct determination of serum TIBC the Fe(III)-saturating reagent must be able to correct an abnormally high serum pH due to a subnormal CO2 content of the sample. Such low CO2 contents are frequently found in reconstituted quality control sera. Detailed studies on combinations of mixtures of serum with varying pH and Fe(III)-saturating solutions with increasing amounts of added acid revealed a linear equation of the minimum amount of acid needed in relation to the original serum pH.
荷兰缺乏关于质量控制评估试验结果的令人满意的文献证据和经验,这促使人们重新考虑人血清和对照血清中总铁结合力(TIBC)的测定方法。研究发现,为了正确测定血清TIBC,铁(III)饱和试剂必须能够校正由于样品中二氧化碳含量低于正常水平而导致的异常高的血清pH值。这种低二氧化碳含量在重构的质量控制血清中经常出现。对不同pH值血清混合物与添加酸量不断增加的铁(III)饱和溶液组合的详细研究揭示了所需最低酸量与原始血清pH值之间的线性方程。